Copyright
©The Author(s) 2023.
World J Clin Infect Dis. Dec 28, 2023; 13(5): 49-57
Published online Dec 28, 2023. doi: 10.5495/wjcid.v13.i5.49
Published online Dec 28, 2023. doi: 10.5495/wjcid.v13.i5.49
Table 1 Recommended schemes for Helicobacter pylori eradication
| Regimen | Drugs (doses) | Duration (d) | Ref. |
| Clarithromycin triple therapy | PPI (standard dose, BID) + clarithromycin (500 mg, BID) + metronidazole (500 mg, BID) or amoxicillin (1000 mg, BID) | 10-14 | [63-65] |
| Bismuth quadruple therapy | PPI (standard dose, BID) + bismuth (QID) + metronidazole (400 mg, QID or 500 mg, TID-QID) + tetracycline (500 mg, QID) | 10-14 | [63-65] |
| Concomitant nonbismuth quadruple therapy | PPI (standard dose, BID), amoxicillin (1000 mg, BID), metronidazole (500 mg, BID) and clarithromycin (500 mg, BID) | 10-14 | [63-65] |
- Citation: Santos LKS, Apolonio JS, Cuzzuol BR, da Costa BT, Lima de Souza Gonçalves V, da Silva Júnior RT, Luz MS, Lemos FFB, Pinheiro SLR, Freire de Melo F. Helicobacter pylori infection in pregnant women: Gastrointestinal symptoms and pregnancy- related disorders. World J Clin Infect Dis 2023; 13(5): 49-57
- URL: https://www.wjgnet.com/2220-3176/full/v13/i5/49.htm
- DOI: https://dx.doi.org/10.5495/wjcid.v13.i5.49